Breaking News Instant updates and real-time market news.

ABY

Atlantica Yield

$21.18

-0.57 (-2.62%)

, CEQP

Crestwood Equity

$24.75

-0.1 (-0.40%)

08:20
08/10/17
08/10
08:20
08/10/17
08:20

Goldman to hold a conference

Power, Utilities, MLPs & Pipeline Conference is being held in New York on August 10.

ABY

Atlantica Yield

$21.18

-0.57 (-2.62%)

CEQP

Crestwood Equity

$24.75

-0.1 (-0.40%)

CLMT

Calumet Specialty Products

$5.30

-0.25 (-4.50%)

DKL

Delek Logistics

$30.10

-0.9 (-2.90%)

ENLC

EnLink Midstream

$16.90

-0.15 (-0.88%)

ENLK

EnLink Midstream Partners

$15.75

-0.06 (-0.38%)

EPD

Enterprise Products

$26.26

0.14 (0.54%)

HESM

Hess Midstream Partners

$19.61

-0.01 (-0.05%)

PEG

PSEG

$45.44

-0.33 (-0.72%)

  • 10

    Aug

  • 16

    Aug

  • 05

    Sep

ABY Atlantica Yield
$21.18

-0.57 (-2.62%)

08/23/16
AVON
08/23/16
NO CHANGE
AVON
Outperform
Abengoa Yield added to Conviction List at Avondale
12/16/16
UBSW
12/16/16
INITIATION
Target $24
UBSW
Buy
Atlantica Yield initiated with a Buy at UBS
UBS analyst Julien Dumoulin-Smith started Atlantica Yield with a Buy rating and $24 price target. The stock's discount should narrow as the impact of the Abengoa restructuring is resolved, the analyst contends.
02/28/17
GUGG
02/28/17
UPGRADE
GUGG
Buy
Atlantica Yield upgraded to Buy from Neutral at Guggenheim
04/12/17
JEFF
04/12/17
INITIATION
Target $22
JEFF
Hold
Atlantica Yield initiated with a Hold at Jefferies
Jefferies analyst Anthony Crowdell started Atlantica Yield with a Hold rating and $22 price target. The analyst finds the stock fairly valued based on cash flows from the current portfolio of assets.
CEQP Crestwood Equity
$24.75

-0.1 (-0.40%)

08/02/17
STFL
08/02/17
UPGRADE
Target $28
STFL
Buy
Crestwood Equity upgraded to Buy from Hold at Stifel
Stifel analyst Selman Akyol upgraded Crestwood Equity to Buy and raised its price target to $28 from $27 following the strong Q2 report and higher guidance. The analyst expects distribution growth in 2018 and said shares provide a solid opportunity for small cap MLP investors.
01/12/17
01/12/17
UPGRADE
Target $27

Outperform
Crestwood Equity upgraded to Outperform at Raymond James
As previously reported, Raymond James upgraded Crestwood Equity to Outperform from Market Perform and established a $27 price target. Analyst Darren Horowitz said Crestwood has reshaped its capital structure and materially improved its operational risk profile and has increased confidence in the ability of Crestwood's balance sheet and diversified midstream capabilities support the current distribution level in today's environment.
01/12/17
RAJA
01/12/17
UPGRADE
RAJA
Outperform
Crestwood Equity upgraded to Outperform from Market Perform at Raymond James
12/14/16
GSCO
12/14/16
INITIATION
Target $30
GSCO
Buy
Crestwood Equity initiated with a Buy at Goldman
Goldman Sachs analyst Jerren Holder started Crestwood Equity Partners with a Buy rating and $30 price target. The analyst sees upside to 2017 EBITDA consensus estimates.
CLMT Calumet Specialty Products
$5.30

-0.25 (-4.50%)

05/10/17
WELS
05/10/17
UPGRADE
WELS
Outperform
Calumet upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Roger Read upgraded Calumet Specialty Products Partners to Outperform saying operational improvements and deleveraging and expansion of the core Specialty Products segment should drive share appreciation. The analyst has a $6 price target for the shares.
03/24/17
03/24/17
DOWNGRADE
Target $3

Underperform
Calumet Specialty Products downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Edward Westlake downgraded Calumet Specialty Products to Underperform from Neutral saying it continues to be "just too much risk on this one." The analyst also lowered his price target on the shares to $3 from $5.
03/24/17
FBCO
03/24/17
DOWNGRADE
FBCO
Underperform
Calumet Specialty Products downgraded to Underperform at Credit Suisse
09/09/16
09/09/16
INITIATION
Target $6

Market Perform
Calumet Specialty Products initiated with a Market Perform at FBR Capital
FBR Capital analyst Robert Balsamo initiated Calumet Specialty Products with a Market Perform and $6 price target given volatile margins, uncertainty in fuel margin recovery, and high leverage remain headwinds for the partnership.
DKL Delek Logistics
$30.10

-0.9 (-2.90%)

01/13/17
WELS
01/13/17
NO CHANGE
WELS
Delek Logistics price target raised to $37-39 from $29-$32 at Wells Fargo
Wells Fargo increased its price target on Delek Logistics (DKL) after the company announced that it had acquired the remaining 53% stake in Alon USA Energy (ALJ). Wells raised its outlook for Delek's distribution growth to a three year CAGR of 8.4%, "predicated on the dropdown of Alon's logistics assets." Wells increased its 2017 DCF forecast for the company to $2.90 from $2.62 "to reflect the assumed dropdown acquisition" It keeps an Outperform rating on the shares. .
03/24/17
03/24/17
DOWNGRADE
Target $13

Neutral
Alon USA Energy downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Edward Westlake downgraded Alon USA Energy (ALJ) to Neutral from Outperform saying that both Delek Logistics (DKL) and by extension Alon USA Energy look close to fully valued. The analyst notes that the latter has had a strong rally over the last 6 months, pulled up by Delek Logistics' offer to acquire the remaining 52% of outstanding shares for an exchange rate of 50.4%. Westlake raised his price target on Alon USA Energy's shares to $13 from $12.
07/05/17
LEHM
07/05/17
INITIATION
Target $33
LEHM
Equal Weight
Delek Logistics reinstated with an Equal Weight at Barclays
Barclays analyst Theresa Chen reinstated Delek Logistics with an Equal Weight rating and $33 price target.
07/05/17
07/05/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ENLC EnLink Midstream
$16.90

-0.15 (-0.88%)

03/10/17
03/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ares Management (ARES) reinstated with a Neutral at Goldman. 2. Insteel (IIIN) initiated with a Buy at Longbow. 3. Century Casinos (CNTY) initiated with a Buy at Aegis. 4. EnLink Midstream Partners (ENLK) and EnLink Midstream (ENLC) were initiated with a Neutral at Janney Capital. 5. PennantPark Floating Rate (PFLT) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/17
GUGG
04/17/17
INITIATION
GUGG
Neutral
EnLink Midstream initiated with a Neutral at Guggenheim
Guggenheim analyst Matthew Phillips initiated EnLink Midstream with a Neutral rating and a $18 price target.
07/12/17
JEFF
07/12/17
UPGRADE
Target $15
JEFF
Hold
EnLink Midstream upgraded to Hold from Underperform at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded EnLink Midstream to Hold citing a more reasonable risk/reward profile amid "subdued" sentiment for Master Limited Partnership. The analyst lowered his price target for the shares to $15 from $16.
08/02/17
MUFG
08/02/17
UPGRADE
Target $19
MUFG
Neutral
EnLink Midstream upgraded to Neutral from Underweight at MUFG
MUFG analyst Barrett Blaschke upgraded EnLink Midstream to Neutral citing expected earnings growth from the Central Oklahoma Tall Oak assets as well as the likelihood for near-term dividend growth. The analyst keeps a $19 price target for the shares.
ENLK EnLink Midstream Partners
$15.75

-0.06 (-0.38%)

04/17/17
GUGG
04/17/17
INITIATION
GUGG
Neutral
EnLink Midstream Partners initiated with a Neutral at Guggenheim
Guggenheim analyst Matthew Phillips initiated EnLink Midstream Partners with a Neutral rating and a $18 price target.
06/15/17
MSCO
06/15/17
DOWNGRADE
Target $19
MSCO
Equal Weight
EnLink Midstream Partners downgraded to Equal Weight at Morgan Stanley
Morgan Stanley analyst Tom Abrams downgraded EnLink Midstream Partners to Equal Weight from Overweight and lowered its price target to $19 from $20 citing challenging cash flow and funding dynamics heading into 2018.
06/16/17
STFL
06/16/17
UPGRADE
STFL
Buy
EnLink Midstream Partners upgraded to Buy from Hold at Stifel
06/16/17
STFL
06/16/17
UPGRADE
STFL
Buy
EnLink Midstream Partners upgraded based on valuation at Stifel
As ntoed earlier, Stifel upgraded EnLink to Buy from Hold. Analyst Brian J. Brungardt, Jr. upgraded the stock based on valuation,. He says that the partnership is exposed "to arguably the two best unconventional liquids basins." Target remains $18.
EPD Enterprise Products
$26.26

0.14 (0.54%)

06/15/17
06/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. La Quinta (LQ) upgraded to Overweight from Equal Weight at Morgan Stanley with the firm's analyst indicating a more bullish outlook for lodging demand given the stronger economy and raised La Quinta estimates, and notes shares have underperformed year-to-date. 2. Paccar (PCAR) upgraded to Buy from Neutral at Goldman Sachs with analyst Jerry Revinch saying he is positive on the company's prospects to further improve its industry-leading returns on capital. 3. Thomson Reuters (TRI) upgraded to Outperform from Neutral at Macquarie with analyst Giasone Salati saying he now believes the company is well positioned for what might be a once-in-a-decade boost in demand for services by MIFID II investment firms. 4. Beazer Homes (BZH) upgraded to Outperform from Neutral at Wedbush with analyst Jay McCanless citing what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." 5. Enterprise Products (EPD) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Tom Abrams citing relative valuation and said the company should benefit from improving ethane markets over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/17
MSCO
06/15/17
UPGRADE
MSCO
Overweight
Enterprise Products upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Tom Abrams upgraded Enterprise Products to Overweight from Equal Weight citing relative valuation and said the company should benefit from improving ethane markets over the next few years.
04/21/17
MACQ
04/21/17
INITIATION
Target $32
MACQ
Outperform
Enterprise Products initiated with an Outperform at Macquarie
Macquarie analyst Andrew Weisel initiated Enerprise Products with an Outperform and a $32 price target saying it is a high quality, well-respected company with an impressive track record of consistency.
04/17/17
GUGG
04/17/17
INITIATION
GUGG
Buy
Enterprise Products initiated with a Buy at Guggenheim
Guggenheim analyst Matthew Phillips initiated Enterprise Products with a Buy rating and a $32 price target.
HESM Hess Midstream Partners
$19.61

-0.01 (-0.05%)

05/02/17
SBSH
05/02/17
INITIATION
Target $28
SBSH
Neutral
Hess Midstream Partners initiated with a Neutral at Citi
Citi analyst Mirek Zak started Hess Midstream Partners with a Neutral rating and $28 price target.
05/01/17
05/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Service Corp. (SCI) initiated with a Buy at Deutsche Bank. 2. Schneider National (SNDR) was initiated with a Peer Perform at Wolfe Research, as a 'Top Pick' at Morgan Stanley, a Buy at UBS and BofA/Merrill, an Outperform at Wells Fargo, Baird, and Credit Suisse, as well as an Overweight at JPMorgan. 3. e.l.f. Beauty (ELF) was assumed with an Overweight at Piper Jaffray, while the firm resumed Estee Lauder (EL) and Ulta Beauty (ULTA) with an Overweight. 4. Hess Midstream Partners (HESM) was initiated with an Equal Weight at Morgan Stanley, an Overweight at MUFG and JPMorgan, and a Buy at Goldman Sachs. 5. Centennial Resource Development (CDEV) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/17
MSCO
05/01/17
INITIATION
Target $27
MSCO
Equal Weight
Hess Midstream Partners initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Tom Abrams initiated Hess Midstream Partners with an Equal Weight and a $27 price target saying valuation seems fair.
05/01/17
MUFG
05/01/17
INITIATION
Target $30
MUFG
Overweight
Hess Midstream Partners initiated with an Overweight at MUFG
MUFG analyst Barrett Blaschke started Hess Midstream Partners with an Overweight rating and $30 price target. The company offers investors stable cash flow assets with a plan for consistent distribution growth, the analyst contends.
PEG PSEG
$45.44

-0.33 (-0.72%)

04/19/17
MZHO
04/19/17
INITIATION
Target $44.5
MZHO
Neutral
PSEG initiated with a Neutral at Mizuho
Mizuho analyst Paul Fremont initiated PSEG with an Neutral and a $44.50 price target given regulatory risk at the state and Federal levels, as well as risk from commodity exposure.
05/11/17
DBAB
05/11/17
NO CHANGE
Target $14
DBAB
Buy
Calpine unlikely to go private above $16 per share, says Deutsche Bank
Deutsche Bank analyst Abe Azar sees few strategic acquirers for Calpine (CPN), making going private or remaining public the most likely outcomes in his view. The Wall Street Journal reported yesterday that the company is exploring a sale. Market power issues in Texas make a combination with Vistra Energy (VST) or NRG Energy (NRG) unlikely, and while PSEG (PEG) and Exelon (EXC) could afford buying Calpine, such a deal would be a shift in strategy for both. The analyst finds it unlikely that a go-private deal gets done much north of $16 per share. He believes, however, that a mid-teens per share takeout is possible "with some creative structuring." Even without a deal, Calpine offers value based on its cash flow profile, Azar contends. The analyst reiterates a Buy rating on Calpine with a $14 price target.
05/24/17
FBCO
05/24/17
NO CHANGE
FBCO
Outperform
Exelon a net winner despite 'disappointing' 2020/21 auction, says Credit Suisse
Following PJM Interconnection's annual capacity auction, Credit Suisse analyst Michael Weinstein called Exelon a net winner despite "disappointing" RPM results for the 2020/21 capacity auction. The results for the EMAAC area should help drive a net positive result for Exelon assuming the same amount of capacity cleared year-over-year, he indicated. PSEG (PEG) and Calpine (CPN)are also "net beneficiaries," while Dynegy (DYN), NRG Energy (NRG) and FirstEnergy (FE) will "bear the brunt of a poor RTO showing," Weinstein tells investors.
07/17/17
WOLF
07/17/17
UPGRADE
WOLF
Peer Perform
PSEG upgraded to Peer Perform from Underperform at Wolfe Research

TODAY'S FREE FLY STORIES

BKD

Brookdale Senior Living

$10.42

0.11 (1.07%)

08:52
11/20/17
11/20
08:52
11/20/17
08:52
Recommendations
Brookdale Senior Living analyst commentary  »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
11/20/17
11/20
08:50
11/20/17
08:50
General news
U.S. equities are trading moderately firmer »

U.S. equities are trading…

ACOR

Acorda Therapeutics

$17.80

0.55 (3.19%)

08:49
11/20/17
11/20
08:49
11/20/17
08:49
Technical Analysis
Technical View: Acorda Therapeutics down on end of tozadenant development »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

KO

Coca-Cola

$45.71

-0.84 (-1.80%)

08:46
11/20/17
11/20
08:46
11/20/17
08:46
Recommendations
Coca-Cola analyst commentary  »

Coca-Cola investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$40.82

8.97 (28.16%)

08:45
11/20/17
11/20
08:45
11/20/17
08:45
Recommendations
Foot Locker analyst commentary  »

Foot Locker price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
11/20/17
11/20
08:45
11/20/17
08:45
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

08:43
11/20/17
11/20
08:43
11/20/17
08:43
Hot Stocks
EU extends license for Janssen's Zytiga plus prednisone »

Janssen-Cilag…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

LIVN

LivaNova

$84.32

0.04 (0.05%)

08:42
11/20/17
11/20
08:42
11/20/17
08:42
Recommendations
LivaNova analyst commentary  »

LivaNova received fair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

MNST

Monster Beverage

$62.17

0.17 (0.27%)

, KO

Coca-Cola

$45.71

-0.84 (-1.80%)

08:40
11/20/17
11/20
08:40
11/20/17
08:40
Downgrade
Monster Beverage, Coca-Cola rating change  »

Monster Beverage…

MNST

Monster Beverage

$62.17

0.17 (0.27%)

KO

Coca-Cola

$45.71

-0.84 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NQ

NQ Mobile

$4.05

-0.05 (-1.22%)

08:40
11/20/17
11/20
08:40
11/20/17
08:40
Hot Stocks
NQ Mobile provides update on FL Mobile Divestment »

NQ Mobile provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENSG

Ensign Group

$23.77

0.22 (0.93%)

08:38
11/20/17
11/20
08:38
11/20/17
08:38
Recommendations
Ensign Group analyst commentary  »

Ensign Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$20.29

0.03 (0.15%)

, CAVM

Cavium

$75.83

-0.47 (-0.62%)

08:37
11/20/17
11/20
08:37
11/20/17
08:37
Hot Stocks
Marvell: Cavium deal doesn't include divestitures, changes to Cavium's portfolio »

On the conference call…

MRVL

Marvell

$20.29

0.03 (0.15%)

CAVM

Cavium

$75.83

-0.47 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

BKS

Barnes & Noble

$7.45

0.35 (4.93%)

08:35
11/20/17
11/20
08:35
11/20/17
08:35
Hot Stocks
Barnes & Noble announces Black Friday weekend deals »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

ARAY

Accuray

$4.80

-0.1 (-2.04%)

08:35
11/20/17
11/20
08:35
11/20/17
08:35
Technical Analysis
Technical View: Accuray rallies in pre-market »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNUS

Genius Brands

$2.88

0.02 (0.70%)

08:34
11/20/17
11/20
08:34
11/20/17
08:34
Hot Stocks
Genius Brands signs multiple content sales deals for children's programming »

Genius Brands expands the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$34.95

-0.33 (-0.94%)

08:34
11/20/17
11/20
08:34
11/20/17
08:34
Initiation
Aimmune initiated  »

Aimmune initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

WOR

Worthington

$40.24

0.03 (0.07%)

08:33
11/20/17
11/20
08:33
11/20/17
08:33
Hot Stocks
WAVE to sell EMEA, Pacific Rim units »

Worthington (WOR)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIV

On Track Innovations

$1.13

-0.01 (-0.88%)

08:32
11/20/17
11/20
08:32
11/20/17
08:32
Hot Stocks
On Track Innovations: UNO 6 selected by CityEV as cashless payment solution »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MDSO

Medidata

$68.64

-0.85 (-1.22%)

08:32
11/20/17
11/20
08:32
11/20/17
08:32
Hot Stocks
Medidata, MEL MEDICAL announce multi-year Medidata eTMF agreement »

Medidata announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PNTR

Pointer Telocation

$17.55

-0.2 (-1.13%)

08:30
11/20/17
11/20
08:30
11/20/17
08:30
Downgrade
Pointer Telocation rating change  »

Pointer Telocation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZH

Beazer Homes

$20.50

0.04 (0.20%)

08:29
11/20/17
11/20
08:29
11/20/17
08:29
Recommendations
Beazer Homes analyst commentary  »

Beazer Homes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:28
11/20/17
11/20
08:28
11/20/17
08:28
Conference/Events
The Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

DG

Dollar General

$85.50

0.59 (0.69%)

, DLTR

Dollar Tree

$94.61

-0.02 (-0.02%)

08:28
11/20/17
11/20
08:28
11/20/17
08:28
Recommendations
Dollar General, Dollar Tree analyst commentary  »

Dollar General price…

DG

Dollar General

$85.50

0.59 (0.69%)

DLTR

Dollar Tree

$94.61

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

OMI

Owens & Minor

$19.14

0.23 (1.22%)

08:27
11/20/17
11/20
08:27
11/20/17
08:27
Recommendations
Owens & Minor analyst commentary  »

Owens & Minor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$102.23

0.32 (0.31%)

08:26
11/20/17
11/20
08:26
11/20/17
08:26
Upgrade
National Beverage rating change  »

National Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.